Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07606443

COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care

This study will test a novel intervention to facilitate family-centered communication among Hispanic/Latino (H/L) young adult childhood cancer survivors (YA-CCS), their support persons, and their clinicians through collaboration between the clinic and a community-based organization.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Stanford University

Palo Alto, California, 94304, United States

Location contact

Stephanie Smith, MD, MPH

CONTACT

[email protected]

209-609-0208

Stephanie Smith, MD, MPH

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Childhood cancer survivor previously treated with chemotherapy and/or radiation therapy
  • Currently age 18-25 years
  • Identifies as Hispanic/Latino
  • Currently ≥5 years post cancer diagnosis
  • Fluent in English or Spanish
  • Receives medical care at Stanford
  • Lives within Jacob's Heart service area (zip codes within Monterey, Santa Cruz, Santa Clara, San Benito Counties: https://www.jacobsheart.org/service-area)
  • Ability to understand and the willingness to provide written informed consent.

Exclusion criteria

  • Lack of proficiency in written and spoken English or Spanish

Treatment and study plan

Family-Centered Communication Intervention

Behavioral

A novel family-centered communication intervention designed to facilitate communication among Young Adult Cancer Survivors (YA-CCS), their chosen support person, and clinicians through collaboration between the clinic and a community-based organization. The intervention includes pre-visit and post-visit sessions delivered by a community health worker and timed around a standard-of-care survivorship clinic visit.

Primary outcomes

  1. Proportion of invited young adult cancer survivor-support person dyads enrolled

    Time frame: From recruitment initiation through completion of study enrollment, up to 24 months

    Feasibility assessed by the proportion of invited dyads who enroll in the study.

  2. Proportion of enrolled young adult cancer survivors completing all intervention components

    Time frame: From intervention initiation through intervention completion, up to 3 weeks

    Feasibility assessed by the proportion of enrolled young adult cancer survivor participants who complete all intervention components.

  3. Mean Theoretical Framework of Acceptability questionnaire score

    Time frame: Post-intervention, within 2 months after intervention completion

    Acceptability assessed using participant-reported Theoretical Framework of Acceptability (TFA) questionnaire scores. Scores range from 1-5, with higher scores indicating greater acceptability.

  4. Mean Satisfaction With Visit Preparation questionnaire score

    Time frame: Post-intervention, within 2 months after intervention completion

    Acceptability assessed using participant-reported Satisfaction With Visit Preparation questionnaire scores. Scores range from -10 to 10, with higher scores indicating greater satisfaction.

Study contacts

Contact information is provided by the study sponsor or research team.

Stephanie Smith, MD, MPH

CONTACT

[email protected]

209-609-0208

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
May 26, 2026
Registry last updated
May 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.